DAFTAR PUSTAKA

1. Semelka M, Gera J, Usman S. Sick sinus syndrome: a review. Am Fam

Physician. 2013 May 15. 87(10):691-6. [Medline].
2. What is an arrhythmia? National Heart, Lung, and Blood Institute.
http://www.nhlbi.nih.gov/health/health-topics/topics/arr/. Accessed Dec. 27,
2013.
3. Genz LI. Sinus bradycardia. http://www.uptodate.com/home. Accessed Dec.
27, 2013.
4. Fuster V, ed. et al. Hurst's The Heart. 13th ed. New York, N.Y. The McGrawHillCompanies;2011.http://accessmedicine.mhmedical.com/content.aspx?
bookid=376&sectionid=40279772&jumpsectionID=40287349. Accessed Dec
27, 2013.
5. Longo DL, et al. Harrison's Online. 18th ed. New York, N.Y.: The McGrawHillCompanies;2012.http://accessmedicine.mhmedical.com/content.aspx?
bookid=331&sectionid=40727005. Accessed Dec. 27, 2013.
6. Bradycardia Slow heart rate. American Heart Association.
http://www.heart.org/HEARTORG/Conditions/Arrhythmia/AboutArrhythmia/
Bradycardia-Slow-Heart-Rate_UCM_302016_Article.jsp. Accessed Dec. 27,
2013.
7. What is an electrocardiogram? National Heart, Lung, and Blood Institute.
http://www.nhlbi.nih.gov/health/health-topics/topics/ekg/. Accessed Jan. 13,
2013.
8. Hayes
DL.
Indications
for
permanent
cardiac
http://www.uptodate.com/home. Accessed Jan. 13, 2014.

pacing.

9. Prevention & treatment of arrhythmia. American Heart Association.

http://www.heart.org/HEARTORG/Conditions/Arrhythmia/PreventionTreatm
entofArrhythmia/Prevention-Treatment-ofArrhythmia_UCM_002026_Article.jsp. Accessed Jan. 8, 2014.
10. Link MS, Estes NAM. Athletes and arrhythmias. J Cardiovasc
Electrophysiol. 2010;21:1-6.
11. Keith A, Flack M. The form and nature of the muscular connections between
the primary divisions of the vertebrate heart. J Anat Physiol. 1907;41:172-89.

12. Baruscotti M, Robinson RB. Electrophysiology and pacemaker function of

the developing sinoatrial node. Am J Physiol Heart Circ Physiol.
2007;293:H2613-23.
13. Moorman AF, de Jong F, Denyn MM, et al. Development of the cardiac
conduction system. Circ Res. 1998;82:629-44.
14. Boullin J, Morgan JM. The development of cardiac rhythm. Heart.
2005;91:874-5.
15. Rossi L. Anatomopathology of the normal and abnormal AV conduction
system. Pacing Clin Electrophysiol. 1984;7:1101-7.
16. Calvo-Romero JM, Lima-Rodriguez EM. Bradycardia
with ophthalmic beta-blockers. J Postgrad Med. 2003;49:186.

associated

17. Mills TA, Kawji MM, Cataldo VD, et al. Profound sinus bradycardia
due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs.
J La State Med Soc. 2004;156:327-31.
18. Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA 3rd, et
al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for devicebased therapy of cardiac rhythm abnormalities: a report of the American
College of Cardiology Foundation/American Heart Association Task Force on
Practice Guidelines and the Heart Rhythm Society. [corrected]. Circulation.
2012 Oct 2. 126(14):1784-800. [Medline].
19. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G,
Breithardt OA, et al. 2013 ESC Guidelines on cardiac pacing and cardiac
resynchronization therapy: the Task Force on cardiac pacing and
resynchronization therapy of the European Society of Cardiology (ESC).
Developed in collaboration with the European Heart Rhythm Association
(EHRA). Eur Heart J. 2013 Aug. 34(29):2281-329. [Medline].
20. Nolan JP, Morley PT, Vanden Hoek TL, Hickey RW, Kloeck WG, Billi J, et
al. Therapeutic hypothermia after cardiac arrest: an advisory statement by the
advanced life support task force of the International Liaison Committee on
Resuscitation. Circulation. 2003 Jul 8. 108(1):118-21. [Medline].
21. Field JM, Hazinski MF, Sayre MR, Chameides L, Schexnayder SM, Hemphill
R, et al. Part 1: executive summary: 2010 American Heart Association
Guidelines for Cardiopulmonary Resuscitation and Emergency

Cardiovascular Care. Circulation. 2010 Nov 2. 122(18 Suppl 3):S64056. [Medline].

22. Alboni P, Menozzi C, Brignole M, Paparella N, Gaggioli G, Lolli G, et al.
Effects of permanent pacemaker and oral theophylline in sick sinus syndrome
the THEOPACE study: a randomized controlled trial. Circulation.
1997;96(1):260-6.
23. Jose AD, Collison D. The normal range and determinants of the intrinsic heart
rate in man. Cardiovascular research. 1970;4(2):160-7.
24. Edhag O, Swahn A. Prognosis of patients with complete heart block or
arrhythmic syncope who were not treated with artificial pacemakers. A longterm follow-up study of 101 patients. Acta medica Scandinavica.
1976;200(6):457-63.
25. Lamas GA, Knight JD, Sweeney MO, Mianulli M, Jorapur V, Khalighi K, et
al. Impact of rate-modulated pacing on quality of life and exercise capacityevidence from the Advanced Elements of Pacing Randomized Controlled
Trial (ADEPT). Heart rhythm : the official journal of the Heart Rhythm
Society. 2007;4(9):1125-32.
26. Castelnuovo E, Stein K, Pitt M, Garside R, Payne E. The effectiveness and
cost-effectiveness of dual-chamber pacemakers compared with singlechamber pacemakers for bradycardia due to atrioventricular block or sick
sinus syndrome: systematic review and economic evaluation. Health
technology assessment (Winchester, England). 2005;9(43):iii, xi-xiii, 1-246.
27. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G,
Breithardt OA, et al. 2013 ESC guidelines on cardiac pacing and cardiac
resynchronization therapy: the task force on cardiac pacing
and resynchronization therapy of the European Society of Cardiology (ESC).
2013;15(8):1070-118.
28. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA,
et al. Nonvalvular cardiovascular device-related infections. Circulation.
2003;108(16):2015-31.
29. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al.
Risk factors related to infections of implanted pacemakers and cardioverterdefibrillators: results of a large prospective study. Circulation.
2007;116(12):1349-55